Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
Date:11/9/2011

ing Group’s updated data set. Time to death specifically attributed to mammary adenocarcinoma was significantly decreased only in the lorcaserin high-dose group. In a second analysis which assumed deaths due to unspecified mammary tumor in rats with both fibroadenoma and adenocarcinoma were caused by adenocarcinoma, time to death was accelerated in the lorcaserin mid-dose group as well, although the incidence of mammary adenocarcinoma was not increased over controls in the mid-dose group.
  • A series of mechanistic studies that are intended to test whether there is a causal relationship between lorcaserin, prolactin and mammary tumor development in rats is ongoing. Arena expects to complete these studies in time to submit the complete response to the FDA around the end of the year.
  • Assigned the UK's Medicines and Healthcare products Regulatory Agency as marketing authorization application Rapporteur and Sweden's Medical Products Agency as Co-rapporteur. Arena also received approval from the Pediatric Development Committee for its pediatric investigation plan application, which defers all pediatric studies until after European Medicines Agency approval.

  • Other recent developments include:

  • Entered into an equity line of credit agreement with Azimuth Opportunity, L.P., or Azimuth, that provides that, upon the terms and subject to the conditions and limitations set forth in the agreement, Azimuth is committed to purchase up to $50 million worth of shares of Arena common stock over a 24-month term. Arena will determine, at its sole discretion, the timing and amount of any sales of its stock, subject to certain conditions.
  • Presented three posters of new data analyses from the lorcaserin Phase 3 clinical trial program at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society.
  • Announced that Robert E. Hoffman rejoined Arena as Vice President, Finance and Chief Financial Officer.

  • Sched
    '/>"/>

    SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
    2. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
    3. Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
    4. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
    5. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
    6. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
    7. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
    8. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
    9. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
    10. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
    11. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... CAMPBELL, Calif. , July 24, 2014 /PRNewswire/ ... the development of novel interventional devices to facilitate ... United States Patent and Trademark Office has issued ... core technology behind the company,s Lazarus Cover TM ... The Lazarus ReCover is a single-component stent-retriever ...
    (Date:7/24/2014)... 2014 Consolidated Net Profit increased by 43.65 ...   , India Business grew by 20.87% to Rs. ... 4,886.70 Mn Rest of World (ROW) Business grew by ... by 34.53% to Rs. 977.26 Mn Latin America Business ... Glenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical company, today ...
    (Date:7/24/2014)... MEMPHIS, Tenn. , July 24, 2014  In ... time, one in 25 patients has at least one ... and Prevention. What,s more, many of these infections prove ... are causing an alarming number of patient deaths per ... of industry conversation. Consequently, a stronger ...
    Breaking Medicine Technology:Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3
    ... SAN DIEGO , April 26 ADVENTRX Pharmaceuticals, Inc. (NYSE ... reverse stock split is now effective, and the Company,s common stock will ... the market opens today. , , ... The reverse stock split is intended to satisfy the NYSE Amex,s determination, ...
    ... Israel , April 26, 2010 PolyTouch Medical Ltd., a,leading developer ... LeBlanc , MD, MBA, FACS as Medical Advisor. , ... Dr. Karl LeBlanc , past president ... performed the first,laparoscopic hernia repair in 1991 and has since written three medical ...
    Cached Medicine Technology:ADVENTRX Reverse Split Effective; Trading on Adjusted Basis Begins Today 2ADVENTRX Reverse Split Effective; Trading on Adjusted Basis Begins Today 3PolyTouch Medical Ltd. Announces the Appointment of Karl A. LeBlanc, MD, MBA, FACS as Medical Advisor 2PolyTouch Medical Ltd. Announces the Appointment of Karl A. LeBlanc, MD, MBA, FACS as Medical Advisor 3
    (Date:7/24/2014)... York (PRWEB) July 24, 2014 ... ( http://www.injurybeacon.com/granuflo-dialysis/lawsuit/ ) in the U.S. District ... protective order for plaintiff medical information covered by ... According to the July 16th Order, U.S. District ... for Fresenius Medical Care the right to ...
    (Date:7/24/2014)... Amy Norton HealthDay Reporter ... sex-crazed teenage boy may be dead wrong, according to a small ... In interviews with 33 boys between the ages of 14 ... with a girl for the closeness and trust. Very few boasted ... starting a relationship with a girl. "In our culture, we ...
    (Date:7/24/2014)... HealthDay Reporter THURSDAY, July ... don,t view their kids as unhealthy or recognize the health ... study. The children of the families surveyed for the ... Children,s Hospital in Providence, R.I. "A third categorized their ... Dr. Kyung Rhee, now an assistant professor of pediatrics at ...
    (Date:7/24/2014)... found a way to delay or even prevent Alzheimer,s ... the anti-aging protein Klotho can prevent neuron death in ... These findings currently appear in the Journal of ... most frequent age-related dementia affecting 5.4 million Americans including ... more than 40 percent of people over the age ...
    (Date:7/24/2014)... 24, 2014 News Facts , ... has achieved certification for compliance with Department of ... by the DoD Information Assurance Certification and Accreditation ... identified within the DoD as the Enterprise Clinical ... designation from the U.S. Army Medical Materiel Agency. ...
    Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 4Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 3Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 4
    ... way to scan brain tumors and predict which ones will ... ever starts treatment. By linking high water movement in ... 70 percent accuracy which patients, tumors were the least likely ... considers himself lucky. When his aggressive brain cancer returned ...
    ... , , , , ... Hospital scientists lead survey of genome that identifies new genes ... MEMPHIS, Tenn., Aug. 16 Scientists at St. Jude Children,s Research ... percent of childhood acute lymphoblastic leukemia (ALL), including a gene that may ...
    ... never met Sumita B. Mitra, Ph.D. But your teeth ... genius has helped restore millions of decayed, broken, or discolored ... a glass make that water, please to toast ... Cadotte. Millions of people might well do exactly that. Mickols ...
    ... Aug. 16, 2009 Attention all smokeless tobacco users! ... chewing tobacco are safe because they don,t burn and produce ... well-researched tobacco hazards, nitrosamines and nicotine, has discovered a single ... tobacco exposes the user to the same amount of another ...
    ... July 30, 2009 Pregnant women have a higher incidence ... months due to dehydration, according to a study conducted by ... retrospective population-based study was published in the July issue of ... objective of the study was to determine whether the summer ...
    ... Comprehensive health reform proposals now before Congress could help ... 19-29 gain coverage, and such reforms would also help ... lose it, according to a new Commonwealth Fund report. ... in Medicaid and a health insurance exchange with a ...
    Cached Medicine News:Health News:A crystal ball for brain cancer? 2Health News:A crystal ball for brain cancer? 3Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 2Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 3Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 4Health News:'Heroes of Chemistry' for saving teeth, clean water, new high blood pressure drug 2Health News:'Heroes of Chemistry' for saving teeth, clean water, new high blood pressure drug 3Health News:'Heroes of Chemistry' for saving teeth, clean water, new high blood pressure drug 4Health News:New study expands the list of hazardous chemicals in smokeless tobacco 2Health News:Summer heat increases risk of amniotic fluid level deficiency, Ben-Gurion University study reveals 2Health News:Health reform proposals could help 13 million uninsured young adults gain coverage 2Health News:Health reform proposals could help 13 million uninsured young adults gain coverage 3
    TEW hooked micro-retractor blade set....
    ... blades are designed for the retraction of nerves, ... the brain. Equalizes brain retraction pressure. Decreases shear ... Used in conjunction with the Budde Halo Retractor. ... wide and 2 mm and 4 mm wide. ...
    Mini-Vise....
    The Budde Halo Retractor Side Rail Support is designed for the adaptation and attachment of the Budde Halo Brain Retractor System to the operating room table when a conventional skull clamp is not us...
    Medicine Products: